NDC 33342-138 – Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate

Efavirenz 600 mg/1; Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC33342-138

Product details

Brand name
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Macleods Pharmaceuticals Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA204287
Marketed since
September 13, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Efavirenz, emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
33342-138-0730 TABLET, FILM COATED in 1 BOTTLE (33342-138-07)Sep 13, 2021

Other Efavirenz, emtricitabine and tenofovir disoproxil fumarate products